(2S,3S,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-6-[(2R,3S,4R,5R)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Term ID

CHEBI:155489

Synonyms

alpha-D-manno-hexopyranosyl-(1->3)-[alpha-D-manno-hexopyranosyl-(1->6)]-alpha-D-manno-hexopyranosyl-(1->4)-2-amino-2-deoxy-D-gluco-hexopyranose
Man(a1-3)[Man(a1-6)]Man(a1-4)GlcN
WURCS=2.0/2,4,3/[a2122h-1x_1-5_2*N][a1122h-1a_1-5]/1-2-2-2/a4-b1_b3-c1_b6-d1

Definition

References

GlyGen:G95831WD
GlyTouCan:G95831WD

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2S,3S,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-6-[(2R,3S,4R,5R)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype where environments contain (2S,3S,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-6-[(2R,3S,4R,5R)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype modified by environments containing (2S,3S,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-6-[(2R,3S,4R,5R)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype affecting (2S,3S,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-6-[(2R,3S,4R,5R)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Human Disease Model